Empire Genomics, LCC

Provider of molecular karyotyping products and services that advance the field of chromosomal analysis

Empire Genomics is a leading provider of molecular karyotyping products and services that advance the field of chromosomal analysis. Empire’s array products and services help pharmaceutical, biotech, cytogenetic and clinical researchers identify chromosomal abnormalities related to the study of cancer, stem cell biology and numerous other genetic disorders. The company’s proprietary Array CGH (Comparative Genome Hybridization) technology provides one of the highest-resolution views of the human genome, enabling researchers to identify the exact location of any chromosomal deletions and amplifications that can manifest into a genetic diseases phenotype.

Anthony Johnson (President/CEO)

701 Ellicott Street
Buffalo, NY 14203
Phone: +1-716-881-8909